Loading market dashboard
Align Technology, Inc.
ALGNHealthcareNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Align Technology NASDAQ: ALGN CFO John Morici said the company continues to navigate a challenging but stable demand environment, with international markets and dental service organizations offsetting pressure in parts of North America.
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Align Technology, Inc. (ALGN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Align Technology NASDAQ: ALGN executives used a William Blair investor presentation to emphasize the company's broader digital dentistry platform, positioning Invisalign as part of a workflow that spans consumer engagement, scanning, treatment planning, monitoring and retention.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company's fifteenth Annual Research Award Program. “Research and clinical evidence continue to be at the core of.
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Align Technology NASDAQ: ALGN executives highlighted product innovation, financing initiatives and international expansion as key growth drivers during a discussion at the 2026 Stifel Jaws & Paws Conference.
Align Technology, Inc. (ALGN) Presents at Stifel Jaws & Paws Conference 2026 Transcript
CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.
HYDERABAD, India & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced plans to open a new manufacturing facility in Hyderabad, India in 2027, create more than 300 direct jobs, and spend approximately $200 million in both ca.
Here is how Align Technology (ALGN) and Carlsmed, Inc. (CARL) have performed compared to their sector so far this year.
BARCELONA, Spain & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East.
On May 20, 2026, Align Technology Inc (ALGN) shares rose 5.3% today, closing at $163.42. The stock has been trading in a 52-week range from a low of $122.00 to
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te.
ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
Align Technology (ALGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200.0 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved.
ORLANDO, Fla. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared a preview of what orthodontists and their teams can expect from the Company (booth #1643) during the American Association of Orthodontists (AAO) 2026 Annual Session, taking.
Align Technology jumps after Q1 earnings beat as record Invisalign shipments, rising margins and steady global demand drive solid revenue growth.
Total Revenue: $1.041 billion, up 6.2% year-over-year.Clear Aligner Revenue: $856 million, up 7.4% year-over-year.Systems and Services Revenue: $184 million, u
Align Technology, Inc. (ALGN) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Align Technology (ALGN) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.13 per share a year ago.
Align Technology beat Wall Street estimates for first-quarter profit, aided by strong demand for its dental aligners, and announced a $200 million share buyback program, sending shares up as much as 4% in after-market trading.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'26"). Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year. Q1'26 total revenues were favorably impa.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALGN's Q1 report looms with revenues seen rising 4.3% and EPS up 6.1%, as Invisalign demand and iTero adoption drive growth trends.
Sumitomo Mitsui Trust Group Inc. lessened its position in Align Technology, Inc. (NASDAQ: ALGN) by 84.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,169 shares of the medical equipment provider's stock after selling 151,437 shares during the quarter. Sumitomo Mitsui
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align has again been recognized, for the fifth consecutive year, as a Top 100 Global Innovator in the 2026 LexisNexis Innovation Momentum report. Align's continued investment in in.
Align Technology, Inc. (NASDAQ: ALGN - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 4,352,518 shares, a growth of 46.8% from the March 15th total of 2,964,353 shares. Approximately 6.1% of the company's stock are short sold.
Align Technology, Inc. (NASDAQ: ALGN - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $157.87 and traded as high as $171.15. Align Technology shares last traded at $166.87, with a volume of 933,692 shares changing hands. Analyst Ratings Changes A
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Align Technology (ALGN) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2026 financial results on Wednesday, April 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and w.
Pallas Capital Advisors LLC raised its holdings in Align Technology, Inc. (NASDAQ: ALGN) by 108.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,034 shares of the medical equipment provider's stock after acquiring an additional 4,188 shares during the quarter. Pallas Capital
Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
Maridea Wealth Management LLC boosted its stake in shares of Align Technology, Inc. (NASDAQ: ALGN) by 125.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,193 shares of the medical equipment provider's stock after buying an additional
Align Technology, Inc. (NASDAQ: ALGN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target
Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?
The fund is expected to push for strategic measures aimed at boosting shareholder value as the company navigates weaker demand following its pandemic-era peak.
Elliott Investment Management has built a significant stake in Align Technology Inc , the maker of Invisalign teeth-straightening products, Bloomberg News reported on Wednesday, citing people familiar with the matter.
Green Cures and Botanical Distribution (OTCMKTS:GRCU - Get Free Report) and Align Technology (NASDAQ: ALGN - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 88.4%
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Capital International Inc. CA lifted its position in shares of Align Technology, Inc. (NASDAQ: ALGN) by 267.5% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 45,135 shares of the medical equipment provider's stock after purchasing an additional 32,853 shares during the quarter. Capital International
Align Technology, Inc. (ALGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Here is how Align Technology (ALGN) and Biofrontera Inc. (BFRI) have performed compared to their sector so far this year.
Dynamic Technology Lab Private Ltd acquired a new position in Align Technology, Inc. (NASDAQ: ALGN) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,720 shares of the medical equipment provider's stock, valued at approximately $591,000. A number of other hedge funds have
Align Technology, Inc. (ALGN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Clarkston Capital Partners LLC increased its position in Align Technology, Inc. (NASDAQ: ALGN) by 25.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,215 shares of the medical equipment provider's stock after acquiring an additional 28,850 shares during the period.
Focus Partners Advisor Solutions LLC raised its stake in shares of Align Technology, Inc. (NASDAQ: ALGN) by 176.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,864 shares of the medical equipment provider's stock after buying an additional 4,381 shares during
